Introduction 1
With cardiovascular disease (CVD) recognised as a leading cause of morbidity and mortality 2 in the UK, the contribution of major modifiable risk factors, such as diet, are becoming 3 increasingly more important in CVD prevention. A high saturated fatty acid (SFA) intake is 4 associated with an increased risk of coronary heart disease (CHD) and for this reason key 5 public health advice recommends that SFA should contribute less than 10% of total energy 6 (TE) [1] . However UK adults are currently exceeding this recommendation, with SFA intake 7 accounting for 12% of TE [2] . Therefore, there is a need for novel interventions to help 8 reduce or replace the amount of SFA in the diet. In comparison to substitution with 9
carbohydrates, evidence suggests that replacement of SFAs with unsaturated fatty acids 10 (FA) may provide a greater CVD risk reduction [3] . Indeed, lowering intake of SFA, through 11 modification of FA profile of the diet, as opposed to reduction in its total fat content, may 12 reduce cardiovascular events by up to 14% [3] , which could have a major impact on public 13
health. 14
This article will present the current prospective evidence on milk and milk-derived 15 foods in relation to CVD events. The potential of ruminant feeding-based public health 16 strategies aimed at reducing cardiovascular risk markers, through replacement of SFA in 17 milk fat with unsaturated FAs, will also be discussed. 18
Nutrient composition of milk and dairy foods 19
Ruminant milk is nutrient dense and is a key source of energy, protein and micronutrients 20 such as calcium, phosphorus, potassium, iodine and vitamin D [4, 5] . Consequently, 21 reducing dairy consumption, as a means of lowering SFA intake, could lead to inadequate 22 intake of these nutrients, especially in vulnerable infant and elderly populations. 23
Additionally, other nutrients found in the diary matrix may be cardio-protective. 24
Calcium and milk proteins (whey and casein) are linked to the blood pressure regulatory 25 properties of dairy; it is believed that protein-derived bioactive peptides have a role to play 26 in the anti-hypertensive aspects of dairy, in part, through inhibition of the angiotensin-I-27 converting enzyme mechanism [5] . When compared with the intake of their industrially 28 produced counterparts, ruminant trans fatty acids (rTFA) do not appear to have the negative 29 effects on CVD risk, with some studies inferring that their intake may be associated with 30 reduced cardiovascular risk [4, 5] . It is recognised that rTFA are consumed at very small 31 quantities but research is needed to clarify whether increasing rTFA intake, through 32 manipulation of the fatty acid profile of dairy products, affects cardio-metabolic health.
While there are some limited data which suggest that the consumption of milk-derived 34 conjugated linoleic acid (CLA) may be associated with beneficial cardio-protective effects, 35 more conclusive evidence is needed to fully understand the impact of CLA on CVD risk 36 outcomes [6] . 37
Contribution of milk to saturated fat intake 38
Milk and dairy products (excluding butter and composite dairy dishes) contribute to almost 39 one quarter of SFA intake the UK diet [7] . A large portion of energy in milk is derived from 40 fat, with SFA accounting for approximately 70% of total milk fat, predominantly in the form 41 of myristic (C14:0), palmitic (C16:0) and stearic (C18:0) acids. As a result of their major 42 contribution to SFA intake, it has been perceived that the consumption of milk and milk-43 derived products should be limited as a means of reducing the risk of CVD. However, there 44 is good evidence of the contrary, as will be explored further in this article. 45
Milk and cholesterol levels 46
While it is recognised that the effect of SFA on CVD is linked to increases in serum lipids, 47 predominantly LDL-cholesterol (LDL-C), some intervention studies have revealed that milk or 48 dairy fat feeding does not significantly increase this risk marker for CVD and cross-sectional 49 evidence suggests that FAs associated with dairy fat intake may have a beneficial effect on 50 LDL-C particle size distribution; however these findings require further investigation (see 51
[5]). Furthermore, it is recognised that there is a differential effect of dairy product type on 52 CVD risk factors, such that fermented dairy products may have a more favourable effect on 53 blood lipid profiles than intake of butter, matched for fat and SFA content [8] . Although 54 limited data are available, it is hypothesised that the higher calcium content of the cheese 55 may lead to a reduced fat absorption when compared to butter, probably through the 56 intestinal formation of insoluble FA calcium soaps [8] . 57
Prospective evidence on milk/dairy foods and cardiovascular disease 58
There have been a number of overviews published on the relationship between consumption 59 of milk and dairy foods and CVD. To date, the largest was a meta-analysis based on 38 60 cohort studies [9] . This meta-analysis with the addition of data from six recently published 61 studies (see [10] for details) showed that the overall relative risk (RR) for CHD was 0.92, 62 suggesting a reduction of about 8% in those subjects who reported the highest milk/dairy 63 intake, compared with subjects with the lowest intake (17 studies RR: 0. and between low-fat milk and incident CHD [17] . In relation to stroke, the findings were 74 inconsistent, with several studies showing a significant inverse association with low-fat milk 75
[17], low-fat dairy [18] and fermented dairy products [17, 19] , whereas in four other 76 studies the consumption of specific dairy foods was not related to stroke [12, 13, 15, 20] . 77
Overall, the evidence from prospective cohort studies shows that milk/dairy 78 consumption does not increase CVD risk. Conversely, individuals with the highest milk/dairy 79 intake had the lowest risk of CVD. However, the effects of individual dairy foods such as 80 butter and cheese, as well as benefits of fat-reduced milk and SFA-reduced milk are less 81
certain. 82

Modification of the fatty acid profile of ruminant milk 83
Although some argue that the nutrients within the dairy food matrix may act synergistically 84 with SFA to prevent the onset of CVD, the potential additional cardio-protective benefits of 85 replacing milk SFA with cis-MUFA or cis-PUFA, through dietary supplementation of the 86 bovine diet with oil seeds or plant oils (typically rich in C18 MUFA and/or PUFA), needs to be 87 further explored [4, 5] . Supplementation of the diet with oils that are rich in long chain 88 unsaturated FA reduces the mammary gland synthesis of short-and medium chain SFA 89 (C6:0-C16:0) and subsequently increases long-chain FA profile of the milk [4, 5] . 90
Additionally, this strategy has the added benefit of removing SFA from the food chain, whilst 91 maintaining the valuable contribution that milk makes to macro-and micronutrient intake. 92
Modified saturated fat-reduced dairy consumption and cardiovascular disease 93 risk 94
There is a scarcity of randomised controlled trial data that has examined the impact of 95 consuming saturated fat-reduced, unsaturated fat-rich modified milk and dairy products on 96 CVD risk. Although the limited research suggests that intake of modified dairy products may 97 favourably impact on CVD risk markers, an inherent limitation of these studies was a 98 reliance on fasting circulating lipid levels as a biomarker for CVD risk (for detailed review, 99 
Conclusion 117
Milk and milk-derived products are complex, nutrient dense foods but there is some concern 118 that their intake could increase risk of CVD. Despite the significant SFA profile of milk fat, 119 epidemiological evidence and experimental data challenge this perception. Indeed, these 120 data suggest that milk may afford some protection from cardiovascular events, but the 121 evidence is less substantial for other dairy products. There is a need to carry out well-122 designed, human dietary intervention studies to determine whether consumption of modified 123 milk and dairy products, with an unsaturated FA enhanced profile, may provide more 124 protection from CVD in both healthy and at-risk populations. 
